Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
about
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesTrial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapyA Role for Neutrophils in Viral Respiratory Disease.Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.Streptococcus pneumoniae Endopeptidase O (PepO) Elicits a Strong Innate Immune Response in Mice via TLR2 and TLR4 Signaling Pathways.Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.Sakuranetin Inhibits Inflammatory Enzyme, Cytokine, and Costimulatory Molecule Expression in Macrophages through Modulation of JNK, p38, and STAT1TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury.IL-8 and IP-10 expression from human bronchial epithelial cells BEAS-2B are promoted by Streptococcus pneumoniae endopeptidase O (PepO).S100-alarmin-induced innate immune programming protects newborn infants from sepsis.TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target.Versican is Produced by Trif- and Type I Interferon-Dependent Signaling in Macrophages and Contributes to Fine-Control of Innate Immunity in Lungs.Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen.Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells.Kudzu Leaf Extract Suppresses the Production of Inducible Nitric Oxide Synthase, Cyclooxygenase-2, Tumor Necrosis Factor-Alpha, and Interleukin-6 via Inhibition of JNK, TBK1 and STAT1 in Inflammatory Macrophages.Diverse pro-inflammatory endotoxin recognition systems of mammalian innate immunity.
P2860
Q26799997-5427DC23-624F-4A33-8096-8C1575029982Q28067939-ACE7FFFF-D242-4973-8779-3ABDA8290E39Q30234336-FE93065B-4940-4A9B-AF8B-82AF6AA48472Q30398876-56CF8189-2A63-46AC-A688-CD99EB30BE30Q36627425-548856E5-8E32-4089-95D8-2982E2701F82Q37002305-6620EF01-CAC8-4F48-AF60-14DF9F5F7CE3Q37271101-CAFEAAD3-7B04-4926-9E37-E9497F68CFA4Q37642698-141A4262-A640-4F05-99E3-D36542986F1DQ38694284-7461A856-7AC3-47D6-AE3A-48A9F20BFB10Q38811341-17E4087D-4789-46CF-BB8B-87B7188E03F1Q38830698-82C9D241-7A34-45FB-9683-7B3451213371Q40045079-3326C679-1F16-43A0-894B-A8938FD3B1E0Q47665126-1022D3B6-1124-430A-BF47-62D5F1756CB6Q52879746-7C08FBD0-E474-42FD-92B9-65800BB5D7C7Q54951736-07E860CA-8575-4E1A-B7B7-28B5AC0E4798Q55396774-1FFA3D3B-503F-45FC-91F9-F3C1A1BFEBD8
P2860
Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Type I interferon signaling co ...... d by the adaptor protein TRIF.
@ast
Type I interferon signaling co ...... d by the adaptor protein TRIF.
@en
type
label
Type I interferon signaling co ...... d by the adaptor protein TRIF.
@ast
Type I interferon signaling co ...... d by the adaptor protein TRIF.
@en
prefLabel
Type I interferon signaling co ...... d by the adaptor protein TRIF.
@ast
Type I interferon signaling co ...... d by the adaptor protein TRIF.
@en
P2093
P2860
P1433
P1476
Type I interferon signaling co ...... ed by the adaptor protein TRIF
@en
P2093
Carolyn R Casella
Shuvasree SenGupta
Thomas C Mitchell
P2860
P356
10.1126/SCISIGNAL.2005442
P577
2014-11-11T00:00:00Z